Skip to content

Efficacy analysis of intestinal decompression and drainage in the prevention of electrocoagulation syndrome after ESD for colorectal mucosal lesions: a single-center, prospective, randomized, parallel controlled clinical trial

Efficacy analysis of intestinal decompression and drainage in the prevention of electrocoagulation syndrome after ESD for colorectal mucosal lesions: a single-center, prospective, randomized, parallel controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063814
Enrollment
Unknown
Registered
2022-09-17
Start date
2022-09-17
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electrocoagulation syndrome after ESD for colorectal mucosal lesions

Interventions

test group:Postoperative placement of bowel decompression and drainage tube
control group:No bowel decompression and drainage tube placed after surgery

Sponsors

General Hospital of the Northern Theater of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meets the indications for colorectal ESD surgery, and has no other serious systemic diseases such as heart, liver, gallbladder, and pancreas; 2. Age>=18 years, regardless of gender; 3. Normal coagulation function; 4. Volunteer to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women, as well as those who may become pregnant and prepare for pregnancy during clinical trials; 2. The patient also has other serious organic diseases that affect the evaluation of this study, such as severe liver disease, heart disease, kidney disease, etc; 3. Patients who have stopped using antiplatelet and NSAIDS drugs for less than 7 days; 4. Without the ability to engage in autonomous behavior, unable to correctly express one's main complaints, such as mental illness or severe neurosis, and unable to cooperate with this trial; 5. Patients with colorectal submucosal tumors (SMTs); 6. Patients who also participate in other clinical studies that affect the observation of the results of this study; 7. Subjects have clinical data loss or inability to effectively cooperate with follow-up; 8. Other researchers believe that it is not suitable for inclusion in the group.

Design outcomes

Primary

MeasureTime frame
Incidence of coagulation syndrome;

Secondary

MeasureTime frame
Other complication rates;Postoperative body temperature;postoperative C-reactive protein;Postoperative abdominal pain visual analogue scale (VAS) scale;Postoperative time to remove intestinal decompression and drainage tube, etc.;

Countries

China

Contacts

Public ContactZhuoYang

General Hospital of the Northern Theater of the Chinese People's Liberation Army

yangzhuocy@163.com+86 13309888172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026